Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMERALD study of enobosarm in early breast cancer
ISRCTN12213700Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- Mar 2017
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of enobosarm in breast cancer (2 arms), sponsored by University of Liverpool. Primary endpoint: Change in Ki67. Started Mar 2017; status: completed.
02
Drugs
enobosarm
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN12213700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12213700.